Symbiotec Pharmalab IPO enters its final bidding day with 5.31 times overall subscription and a Rs 285 GMP. The Rs 1,757 crore issue is priced at Rs 938–988 per share, with listing expected on September 1. Proceeds will partly repay debt, while investors weigh strong demand against premium valuation and risks.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.